meloxicam 15 MG Oral Tablet
1 INDICATIONS AND USAGE Meloxicam tablet USP is a non-steroidal anti-inflammatory drug indicated for: Osteoarthritis (OA) ( 1.1 ) Rheumatoid Arthritis (RA) ( 1.2 ) Juvenile Rheumatoid Arthritis (JRA) in patients who weigh ≥60 kg ( 1.3 ) 1.1 Osteoarthritis (OA Meloxicam tablets USP are indicated for relief of the signs and symptoms of Osteoarthritis [see Clinical Studies ( 14.1 )] . 1.2 Rheumatoid Arthritis (RA) Meloxicam tablets USP are indicated for relief of the signs and symptoms of Rheumatoid Arthritis [see Clinical Studies ( 14.1 )] . 1.3 Juvenile Rheumatoid Arthritis (JRA) Pauciarticular and Polyarticular Course Meloxicam tablets USP are indicated for relief of the signs and symptoms of pauciarticular or polyarticular course Juvenile Rheumatoid Arthritis in patients who weigh ≥60 kg [see Dosage and Administration ( 2.4 ) and Clinical Studies ( 14.2 )] .
Lupin Pharmaceuticals, Inc.
15
Related Pills
Meloxicam meloxicam 15 MG Oral Tablet
Lupin Pharmaceuticals, Inc.
ranitidine 150 MG as ranitidine hydrochloride 168 MG Oral Tablet
Dr. Reddy's Laboratories Limited
meloxicam 15 MG Oral Tablet
International Labs, Inc.
valacyclovir hydrochloride tablet
film coated
valacyclovir hydrochloride 500 mg tablet
wockhardt usa llc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING
MELOXICAM Tablets USP are available as light yellow coloured, round, biconvex tablets, plain on one side and debossed with '7.5' on other side containing
MELOXICAM 7.5 mg or as light yellow coloured, oval shaped, biconvex tablets, plain on one side and debossed with '15' on other side containing
MELOXICAM 15 mg.
MELOXICAM Tablets USP, 7.5 mg are available as follows: Bottles of 100 NDC 68180-501-01 Bottles of 1000 NDC 68180-501-03
MELOXICAM Tablets USP, 15 mg are available as follows: Bottles of 100 NDC 68180-502-01 Bottles of 1000 NDC 68180-502-03 Storage Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Keep
MELOXICAM tablets USP in a dry place. Dispense tablets in a tight container. Keep this and all medications out of the reach of children.